早期禁食的临床结果与严重高血症成年人的缓慢校正率相比:一项比较有效性研究
Nuttapol Pattamin1, Anan Chuasuwan1
1Kidney Excellence Center, Bhumibol Adulyadej Hospital, Royal Thai Air Force, Bangkok, Thailand.
Journal of critical care
|November 15, 2025
概括
在危急病患者中快速纠正严重高血症显著降低了30天死亡率,并改善了生存率. 这种方法还可以减少重症监护室和住院时间,为患者提供更好的治疗结果.
科学领域:
- 关键护理医学 关键护理医学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 临床研究 临床研究
背景情况:
- 严重的高血血 (血清≥155 mmol/L) 在危急疾病中具有高死亡风险.
- 至关重症患者严重高血的最佳纠正率尚不清楚.
研究的目的:
- 为了比较快速 (>0.5 mmol/L/h) 与缓慢 (≤0.5 mmol/L/h) 血清修正的结果,在严重高血症的危急病患者中,在前24小时内进行血清修正.
主要方法:
- 使用MIMIC-IV数据库进行了目标试验模拟.
- 应用了倾向性得分匹配和每协议分析来比较快速与缓慢的血清度校正组.
- 主要结局是30天死亡率;次要结局包括无医院生存率和住院时间.
主要成果:
- 快速校正显著降低了30天死亡率 (调整HR0.49) 和改善了30天无医院生存率 (调整HR1.75).
- 接受快速校正的患者经历了更短的重症监护室 (ICU) 和住院时间.
- 敏感性分析证实了这些发现的可靠性.
结论:
- 在严重病情严重的成年人中,严重高血的早期快速纠正与死亡率的降低有关.
- 与缓慢校正相比,快速的血清正改善了无医院生存率,并减少了ICU和住院时间.
相关概念视频
Acute Kidney Injury V: Interprofessional Care
287
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
287
Heart Failure VI: Adjunct Therapies
243
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
243
Acute Kidney Injury VI: Nursing Management
373
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
373
Disorder of Water Balance
2.3K
Water balance disorders are medical conditions that occur when there is a deviation from the body's water volume or osmolarity, disrupting normal homeostasis and leading todehydration, hypotonic hydration, hyperhydration, edema, or water intoxication.
Dehydration
Dehydration occurs when the body loses fluids (particularly water).
Causes:
The major causes of dehydration include excessive sweating, fever, vomiting, diarrhea, and diuresis.
Signs and Symptoms:
Symptoms primarily include intense...
Dehydration
Dehydration occurs when the body loses fluids (particularly water).
Causes:
The major causes of dehydration include excessive sweating, fever, vomiting, diarrhea, and diuresis.
Signs and Symptoms:
Symptoms primarily include intense...
2.3K
Antihypertensive Drugs: Potassium-Sparing Diuretics
2.2K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.2K
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
200
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
200


